Fig. 1From: Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort studyPatient enrollment flow diagram: 704 patients with SLE were enrolled. CNIs, calcineurin inhibitorsBack to article page